Cancer Gene Therapy - Table of Contents alert Volume 20 Issue 9

Advertisement Personalized breast cancer management  Topic Editor: Parvin Mehdipour¦Submission deadline: 30 Sep 2013   This research topic from Frontiers in Genetics seeks to prove an active link for researchers in this field and to help strengthen a link between Genetics, Cell Biology and clinics and motivate the translational research and education in the cancer clinics, hospitals and cancer research centres.  Find out more on how you can contribute to this Research Topic or even host your own.   TABLE OF CONTENTS Volume 20, Issue 9 (September 2013) In this issue Original Articles Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Nature Communications is ranked #3 in the Multidisciplinary Sciences with an Impact Factor of 10.015* Your research. Our reach. Together we make an impact.  nature.com/naturecommunications  *2012 Journal Citation Reports® (Thomson Reuters, 2013) Original Articles Top Decreasing P-selectin and ICAM-1 via activating Akt: a possible mechanism by which PARG inhibits adhesion of mouse colorectal carcinoma CT26 cells to platelets J Yan, M Li, M D Threadgill, Y Wang and W Fu Cancer Gene Ther 2013 20: 487-492; advance online publication, August 16, 2013; 10.1038/cgt.2013.44 Abstract | Full Text Enhancement of systemic tumor immunity for squamous cell carcinoma cells by an oncolytic herpes simplex virus N Meshii, G Takahashi, S Okunaga, M Hamada, S Iwai, A Takasu, Y Ogawa and Y Yura Cancer Gene Ther 2013 20: 493-498; advance online publication, July 26, 2013; 10.1038/cgt.2013.45 Abstract | Full Text Polo-like kinase 1 inhibition causes decreased proliferation by cell cycle arrest, leading to cell death in glioblastoma J A Pezuk, M S Brassesco, A G Morales, J C de Oliveira, R G de Paula Queiroz, H R Machado, C G Carlotti, Jr, L Neder, C A Scrideli and L G Tone Cancer Gene Ther 2013 20: 499-506; advance online publication, July 26, 2013; 10.1038/cgt.2013.46 Abstract | Full Text Heterogeneous reovirus susceptibility in human glioblastoma stem-like cell cultures S K van den Hengel, R K Balvers, I J C Dautzenberg, D J M van den Wollenberg, J J Kloezeman, M L Lamfers, P A E Sillivis-Smit and R C Hoeben Cancer Gene Ther 2013 20: 507-513; advance online publication, August 2, 2013; 10.1038/cgt.2013.47 Abstract | Full Text Targeted expression of human folylpolyglutamate synthase for selective enhancement of methotrexate chemotherapy in osteosarcoma cells K Bienemann, M S Staege, S J Howe, M Sena-Esteves, H Hanenberg and C M Kramm Cancer Gene Ther 2013 20: 514-520; advance online publication, August 16, 2013; 10.1038/cgt.2013.48 Abstract | Full Text The role of cyclophosphamide in enhancing antitumor efficacy of an adenovirus oncolytic vector in subcutaneous Syrian hamster tumors B A Young, J F Spencer, B Ying, A E Tollefson, K Toth and W S M Wold Cancer Gene Ther 2013 20: 521-530; advance online publication, August 9, 2013; 10.1038/cgt.2013.49 Abstract | Full Text The effects of radiation on antitumor efficacy of an oncolytic adenovirus vector in the Syrian hamster model B A Young, J F Spencer, B Ying, K Toth and W S M Wold Cancer Gene Ther 2013 20: 531-537; advance online publication, August 9, 2013; 10.1038/cgt.2013.50 Abstract | Full Text Advertisement Why Blood Cancer Journal is.. R apid decision and publication I mpact on hematology field G lobal visibility H igh traffic site T otally open access      ..for your research  Submit your research today!  Editor-in-Chief: Dr Nicole Muller-Bérat Killmann Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Cancer Gene Therapy. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.